Unsubstantiated superiority claims for rivastigmine tartrate

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of the American Osteopathic Association 2006-10, Vol.106 (10), p.589-90; author reply 590
Hauptverfasser:	Shah, Shiwan K, Krueger, Paul M
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - drug therapy Cholinesterase Inhibitors - therapeutic use Humans Phenylcarbamates - therapeutic use Rivastigmine Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	90; author reply 590
container_issue	10
container_start_page	589
container_title	The Journal of the American Osteopathic Association
container_volume	106
creator	Shah, Shiwan K Krueger, Paul M
description
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68180113</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68180113</sourcerecordid><originalsourceid>FETCH-LOGICAL-p209t-3b0b19c175062ed84823a276aa6c87bfe06e8d7038b15d7de50dc29ff42f1a953</originalsourceid><addsrcrecordid>eNo1z0tLAzEUhuEslLbW_gWZlbuBk8xMLuBGijcouLHr4WRyIpG5mWSE_nsL1tW3efjgvWIbAKNLyRu-ZjcpfQEIU9d8xdZccSFAqA17OI5psSnjmANmckVaZophiiGfiq7HMKTCT7GI4QdTDp9DGKnIGHM861t27bFPtLvslh2fnz72r-Xh_eVt_3goZwEml5UFy03HVQNSkNO1FhUKJRFlp5X1BJK0U1BpyxunHDXgOmG8r4XnaJpqy-7_fuc4fS-UcjuE1FHf40jTklqpuQbOqzO8u8DFDuTaOYYB46n9761-ARJ1UUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68180113</pqid></control><display><type>article</type><title>Unsubstantiated superiority claims for rivastigmine tartrate</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Shah, Shiwan K ; Krueger, Paul M</creator><creatorcontrib>Shah, Shiwan K ; Krueger, Paul M</creatorcontrib><identifier>ISSN: 0098-6151</identifier><identifier>PMID: 17122027</identifier><language>eng</language><publisher>United States</publisher><subject>Alzheimer Disease - drug therapy ; Cholinesterase Inhibitors - therapeutic use ; Humans ; Phenylcarbamates - therapeutic use ; Rivastigmine ; Treatment Outcome</subject><ispartof>The Journal of the American Osteopathic Association, 2006-10, Vol.106 (10), p.589-90; author reply 590</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17122027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shah, Shiwan K</creatorcontrib><creatorcontrib>Krueger, Paul M</creatorcontrib><title>Unsubstantiated superiority claims for rivastigmine tartrate</title><title>The Journal of the American Osteopathic Association</title><addtitle>J Am Osteopath Assoc</addtitle><subject>Alzheimer Disease - drug therapy</subject><subject>Cholinesterase Inhibitors - therapeutic use</subject><subject>Humans</subject><subject>Phenylcarbamates - therapeutic use</subject><subject>Rivastigmine</subject><subject>Treatment Outcome</subject><issn>0098-6151</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1z0tLAzEUhuEslLbW_gWZlbuBk8xMLuBGijcouLHr4WRyIpG5mWSE_nsL1tW3efjgvWIbAKNLyRu-ZjcpfQEIU9d8xdZccSFAqA17OI5psSnjmANmckVaZophiiGfiq7HMKTCT7GI4QdTDp9DGKnIGHM861t27bFPtLvslh2fnz72r-Xh_eVt_3goZwEml5UFy03HVQNSkNO1FhUKJRFlp5X1BJK0U1BpyxunHDXgOmG8r4XnaJpqy-7_fuc4fS-UcjuE1FHf40jTklqpuQbOqzO8u8DFDuTaOYYB46n9761-ARJ1UUA</recordid><startdate>200610</startdate><enddate>200610</enddate><creator>Shah, Shiwan K</creator><creator>Krueger, Paul M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200610</creationdate><title>Unsubstantiated superiority claims for rivastigmine tartrate</title><author>Shah, Shiwan K ; Krueger, Paul M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p209t-3b0b19c175062ed84823a276aa6c87bfe06e8d7038b15d7de50dc29ff42f1a953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alzheimer Disease - drug therapy</topic><topic>Cholinesterase Inhibitors - therapeutic use</topic><topic>Humans</topic><topic>Phenylcarbamates - therapeutic use</topic><topic>Rivastigmine</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shah, Shiwan K</creatorcontrib><creatorcontrib>Krueger, Paul M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of the American Osteopathic Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shah, Shiwan K</au><au>Krueger, Paul M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Unsubstantiated superiority claims for rivastigmine tartrate</atitle><jtitle>The Journal of the American Osteopathic Association</jtitle><addtitle>J Am Osteopath Assoc</addtitle><date>2006-10</date><risdate>2006</risdate><volume>106</volume><issue>10</issue><spage>589</spage><epage>90; author reply 590</epage><pages>589-90; author reply 590</pages><issn>0098-6151</issn><cop>United States</cop><pmid>17122027</pmid></addata></record>
fulltext	fulltext
identifier	ISSN: 0098-6151
ispartof	The Journal of the American Osteopathic Association, 2006-10, Vol.106 (10), p.589-90; author reply 590
issn	0098-6151
language	eng
recordid	cdi_proquest_miscellaneous_68180113
source	MEDLINE; Alma/SFX Local Collection
subjects	Alzheimer Disease - drug therapy Cholinesterase Inhibitors - therapeutic use Humans Phenylcarbamates - therapeutic use Rivastigmine Treatment Outcome
title	Unsubstantiated superiority claims for rivastigmine tartrate
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A24%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Unsubstantiated%20superiority%20claims%20for%20rivastigmine%20tartrate&rft.jtitle=The%20Journal%20of%20the%20American%20Osteopathic%20Association&rft.au=Shah,%20Shiwan%20K&rft.date=2006-10&rft.volume=106&rft.issue=10&rft.spage=589&rft.epage=90;%20author%20reply%20590&rft.pages=589-90;%20author%20reply%20590&rft.issn=0098-6151&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E68180113%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68180113&rft_id=info:pmid/17122027&rfr_iscdi=true